FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (NASDAQ:GILD) today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Harvoni® (ledipasvir 90 mg/sofosbuvir 400 mg), the first once-daily […]

DEERFIELD, Ill. & MENLO PARK, Calif.–(BUSINESS WIRE)–In the lead up to National HIV Testing Day on June 27, Walgreens and Greater Than AIDS, a leading national public information response to […]